Somaliland Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Somaliland Health Watch.

Press releases published on October 30, 2026

Oct. 30, 2026

Atgam Market Trends and Forecast Analysis Indicate Significant Long-Term Growth Potential

Indeterminate EIN Presswire

Oct. 30, 2026

Attenuvax Market Analysis Report Examining Demand Patterns and Competitive Landscape

Indeterminate EIN Presswire

Oct. 30, 2026

Detailed Atryn Market Report Includes Forecasts, Innovations, and Industry Perspectives

Indeterminate EIN Presswire

Oct. 30, 2026

Werewolf Therapeutics Selected for Oral Presentation and to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 30, 2026

Integra LifeSciences to Highlight Hands-On Education and Neurosurgery Innovation at CNS 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 30, 2026

IRADIMED CORPORATION Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Oct. 30, 2026

Sienna Completes Acquisition in Ottawa

Indeterminate GlobeNewswire

Oct. 30, 2026

Propanc Biopharma Advances Bioanalytical & Immunogenicity Assay Development for Phase 1b First-In-Human Study in up to 50 Advanced Cancer Patients

Indeterminate GlobeNewswire

Oct. 30, 2026

NurExone Demonstrates Consistent Anti-Inflammatory Activity Across Three Separate Batches of Exosomes

Indeterminate GlobeNewswire

Oct. 30, 2026

Polk County Mosquito Control Reduces Aedes aegypti by Up to 95% with Sterile Insect Farms™ Sterile Male Releases

Indeterminate GlobeNewswire

Oct. 30, 2026

Canon Medical and Stereotaxis Collaborate to Advance Robotic Electrophysiology

Indeterminate GlobeNewswire

Oct. 30, 2026

Texas Handicap Parking Placards: HandicapMD Publishes VTR-214 Medical Certification Resource

Indeterminate EIN Presswire

Oct. 30, 2026

Detailed Advanced Melanoma Market Report Includes Forecasts, Innovations, and Industry Insights

Indeterminate EIN Presswire

Oct. 30, 2026

Profound Medical and Cook Medical’s iMRI Division Partner to Expand U.S. TULSA-PRO® Sales Channels and Drive Recurring Revenue Growth

Indeterminate GlobeNewswire

Oct. 30, 2026

Eos SENOLYTIX Reports Interim Data Showing Preserved Physical Function with MitoXcel Geropeptide PTC-2105 in a Second Species, Aged-Rat Study

Indeterminate GlobeNewswire

Oct. 30, 2026

Allarity Therapeutics Secures First Commercial Agreement Under New CLIA Laboratory Services Strategy, Establishing Potential Path to Additional Recurring Revenue

Indeterminate GlobeNewswire

Oct. 30, 2026

Braveheart Bio Announces Upcoming Presentations at the American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire

Oct. 30, 2026

Syndax Announces Participation in November Investor Conferences

Indeterminate GlobeNewswire

Oct. 30, 2026

Acumen Pharmaceuticals Announces Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) for the Treatment of Early Alzheimer’s Disease; Trial Did Not Meet Primary Endpoint

Indeterminate GlobeNewswire

Oct. 30, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Receives FDA Approval of Preservative-Free Ketamine Ahead of November 10 FDA Goal Date

Indeterminate GlobeNewswire